-16. Mai 20191 Min.Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZBMay 16, 2019 Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new...
-29. Apr. 20191 Min.Origenis, A new approach to small molecule drug discoveryApril 29, 2019 A multipart AI-based, drug discovery platform, optimizing compounds for specificity, efficacy, physiochemical properties,...
-26. Apr. 20197 Min.Origenis featured on the cover of Pharma Tech Outlook Drug Discovery and Development edition!